By Dr. Chiaramonte
As my many avid readers will know, my last post on FDA black box warnings highlighted the alarming language on formoterol, contained in the combination asthma therapy Symbicort. Because of a faulty study, known as SMART, black people were deemed at particular risk. At the American College of Allergy, Asthma and Immunology meeting in Phoenix last week, new research showed that black asthmatics can breathe easier, literally.
“The asthma medication budesonide/formoterol (Symbicort) is safe and effective in African-American patients, according to two studies presented here.
“Taken together, the studies suggest that the safety profile of the combination in blacks is similar to that seen in other populations, according to Sheldon Spector, MD, of California Allergy & Asthma Medical Group in Los Angeles, and colleagues.”
For more on this news, click here